Advanced Enzyme Technologies Limited (ADVENZYMES.NS) NSE

Currency In INR

AD

Valuation

Market Cap28.56B
Enterprise Value27.72B
P/E Ratio20.9
PEG Ratio0.73
Price/Sales Ratio4.73
Price/Book Ratio2.16
Enterprise/Revenue4.62
Enterprise/EBITDA12.51

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.23
Operating Margin0.25
AD

Management Effectiveness

Return On Assets0.09
Return On Equity0.11

Income Statement

Revenue7.46B
Revenue/Share66.66
Gross Profit3.5B
EBITDA2.75B
Net Income1.69B
Diluted EPS15.06

Balance Sheet

Total Cash7B
Total Cash/Share62.54
Total Debt320.09M
Total Debt/Equity0.02
Current Ratio9.78
Book Value Per Share150.44

Price History

52-Week Change-4.15
52-Week High419
52-Week Low251.95
Moving Average 50 Days344.73
Moving Average 200 Days315.73

Statistics

Average Volume421,164
Shares Outstanding111.98M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.35
Trailing Annual Dividend Yield0.43
Payout Ratio0.35
Last Split Factor5:1
Last Split DateMay 25, 2017
AD